North America Perfusion Systems Market Size & Outlook
- MedTech
- General Surgery
- Perfusion Systems Market Outlook
- General Surgery
North America Perfusion Systems Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the perfusion systems market
North America perfusion systems market highlights
- The North America perfusion systems market generated a revenue of USD 442.6 million in 2023.
- The market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
- In terms of segment, cardiopulmonary perfusion system was the largest revenue generating application in 2023.
- Cardiopulmonary Perfusion System is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 442.6 million |
| Market revenue in 2030 | USD 599.1 million |
| Growth rate | 4.4% (CAGR from 2023 to 2030) |
| Largest segment | Cardiopulmonary perfusion system |
| Fastest growing segment | Cardiopulmonary Perfusion System |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
| Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
Other key industry trends
- In terms of revenue, North America region accounted for 39.5% of the global perfusion systems market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 373.9 million by 2030.
In 2023, North America dominated the global perfusion systems market. The dominance can be attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, and the high prevalence of respiratory and cardiac disorders. North America faces a significant burden of cardiovascular and respiratory diseases, leading to a rising demand for perfusion systems used in surgeries for these conditions.
The growing number of organ transplants necessitates advanced perfusion systems for organ preservation and viability during the transplant process. Continuous development of perfusion systems with improved functionalities, like Normothermic Machine Perfusion (NMP), fuels market growth.
In January 2024, Penn Medicine announced a significant advancement in liver transplantation with the first successful use of an external perfusion system incorporating a genetically modified pig liver. This technology holds promise as a bridge for patients on the waiting list for organ transplants. The researchers conducted a successful experiment on external liver perfusion.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Perfusion Systems Market Scope
Perfusion Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Getinge AB ADR | View profile | 11,862 | Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 | www.getinge.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| Spectrum Brands Holdings Inc | View profile | 3,100 | 3001 Deming Way, Middleton, WI, United States, 53562 | www.spectrumbrands.com |
| Nipro Corp | View profile | 39,713 | 3-9-3 Honjo-Nishi Kita-ku, Osaka, Japan, 531-8510 | www.nipro.co.jp |
| LivaNova PLC | View profile | 2,900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | www.livanova.com |
| Repligen Corp | View profile | 1,783 | 41 Seyon Street, Building 1, Suite 100, Waltham, MA, United States, 02453 | www.repligen.com |
| Fresenius Medical Care AG | View profile | 119,845 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | www.freseniusmedicalcare.com |
| Xvivo Perfusion AB | View profile | 130 | Gemenskapens gata 9, Mölndal, Sweden, SE-431 53 | www.xvivoperfusion.com |
North America Perfusion Systems Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Perfusion Systems Market Outlook will help companies and investors design strategic landscapes.
Cardiopulmonary Perfusion System was the largest segment with a revenue share of 44.74% in 2023.
Horizon Databook has segmented the North America perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
In 2023, North America dominated the global perfusion systems market. The dominance can be attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, and the high prevalence of respiratory and cardiac disorders. North America faces a significant burden of cardiovascular and respiratory diseases, leading to a rising demand for perfusion systems used in surgeries for these conditions.
The growing number of organ transplants necessitates advanced perfusion systems for organ preservation and viability during the transplant process. Continuous development of perfusion systems with improved functionalities, like Normothermic Machine Perfusion (NMP), fuels market growth.
In January 2024, Penn Medicine announced a significant advancement in liver transplantation with the first successful use of an external perfusion system incorporating a genetically modified pig liver. This technology holds promise as a bridge for patients on the waiting list for organ transplants. The researchers conducted a successful experiment on external liver perfusion.
- North America Perfusion Systems Market Application Outlook (Revenue, USD Million , 2018-2030)
- Cardiopulmonary Perfusion System
- Cell Perfusion System
- Ex-Vivo Organ Perfusion System
Reasons to subscribe to Perfusion Systems Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Perfusion Systems Market Outlook databook
- Our clientele includes a mix of Perfusion Systems Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Perfusion Systems Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Perfusion Systems Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
North America Perfusion Systems Market, 2018-2030 (US$M)
North America perfusion systems market statistics, by application, 2018-2030 (US$M)
